Arizona Pain Specialists’ Only Arizona Pain Center Studying New Chronic Nerve Pain Treatment

Share Article

Arizona Pain Specialists, the premier pain management clinic in Phoenix, AZ, has been selected as the only Arizona pain center to participate in a novel study on chronic nerve pain. This FDA-approved study may unveil a potentially groundbreaking treatment with the use of a peripheral nerve stimulator, and patients who enroll today will be compensated.

The team at Arizona Pain Specialists is dedicated to providing relief for various types of chronic pain, including back, neck, facial, joint, hip and cancer pain, as well as other chronic pain conditions.

“The treatment we are testing in this study may finally provide lasting relief for patients suffering from intractable nerve pain,” says Arizona Pain Specialists’ Research Director, Dr. Ted Swing.

Those who suffer from debilitating chronic nerve pain will now have the chance to try a new, cutting-edge treatment that may rid them of their pain. Arizona Pain Specialists, (http://www.arizonapain.com) a comprehensive pain management clinic in the Phoenix area, is now enrolling patients for a breakthrough study involving the use of a new nerve stimulator to treat peripheral neuralgia — the Bioness StimRouter.

“The treatment we are testing in this study may finally provide lasting relief for patients suffering from intractable nerve pain,” says Arizona Pain Specialists’ Research Director, Dr. Ted Swing.

It is estimated that 20-million Americans suffer from peripheral nerve pain. Peripheral neuralgia refers to chronic pain of the arms, legs or trunk caused by damage to the nerves themselves. This condition can be the result of various causes, including physical trauma or surgical procedures, and is often difficult to treat. Current treatments include non-localized therapies such as spinal cord stimulation and the use of pain medication.

Bioness Inc., an award winning medical device company, is sponsoring this double blind, randomized study, which will enroll 126 patients at up to ten study sites throughout the United States. Patients who suffer from persistent nerve pain in their arms, legs or trunk, and who have been treated for more than three months without relief, may qualify for this study. It is free to participate, and all those who enroll will be financially compensated.

The study tests one method that has been previously effective for treating peripheral neuralgia — peripheral nerve stimulation. Through peripheral nerve stimulation, pain is reduced by delivering non-painful electrical stimulation to the nerve that is the source of an individual’s pain. This stimulation interferes with the pain signals from the affected nerve, resulting in a reduction in perceived pain.

A peripheral nerve stimulator relies on the same principle as a spinal cord stimulator. Spinal cord stimulators are used for individuals experiencing pain from multiple nerves, as the spine is a central route for pain. The stimulator device investigated in this study — the Bioness® StimRouter — consists of a small lead implanted under the skin, as well as an external pulse transmitter and battery, which are attached to the skin externally. This new stimulation device is designed to directly target the pain site for more focused pain relief.

“Our team of physicians have seen great success with spinal cord stimulators for back pain and peripheral neuropathy; we now hope to see the Bioness® StimRouter be more effective in treating nerve pain stemming from a more specific, single nerve,” says Dr. Tory McJunkin, co-founder of Arizona Pain Specialists.

Patients who qualify for this study will have the StimRouter implanted near the site of their pain and programmed two-to four-weeks later. For the first 12 weeks of this study, some patients will receive the treatment stimulation while others receive only control stimulation. However, for the remaining nine months of the study, all patients will receive the treatment stimulation. Patients will have five screening visits over the course of 13 months to assess the devices safety and efficacy at reducing their pain. At the end of the study, if the stimulator is effective for the patients, they may keep their Bioness® StimRouter to maintain permanent pain relief.

The goal of this study is to determine whether or not the Bioness® StimRouter therapy leads to clinically important pain relief in patients with chronic intractable pain from a peripheral nerve origin after three months of treatment. The study will also gather information on side effects associated with the StimRouter electrical stimulation therapy, as stated at Clinicaltrials.gov, a service of the U.S. National Institute of Health.

“We know that chronic pain has a dramatic impact on a patient's quality of life, and as a comprehensive pain center, we strive to provide the most innovative treatment options and many alternatives to pain pills, so our patients can get back to living their lives,” says Dr. McJunkin.

About Arizona Pain Specialists

The team at Arizona Pain Specialists is dedicated to providing relief for various types of chronic pain, including back, neck, facial, joint, hip and cancer pain, as well as other chronic pain conditions. These specialists work with one mission in mind: “to change lives by delivering world-class pain management care that we would want for our own mom and dad.” Dr. Tory McJunkin and Dr. Paul Lynch founded Arizona Pain Specialists after a close family member battled severe, debilitating pain. Arizona Pain Specialists remain passionate about treating those who suffer from chronic pain, with the ultimate goal of providing hope and restoring life.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristen Wesley
Follow us on
Visit website